How to confirm the causes of iron deficiency anemia in young women

June 23, 2009

Iron-deficiency anaemia (IDA) is commonly seen in women aged <50 years. the diagnostic workflow in young women affected by ida is not clearly established. the british society of gastroenterology recommends gastroscopy only in ida women younger than 45 years presenting with gastrointestinal (gi) symptoms. however, symptoms are often mild and aspecific in ida women and the gastroscopy is an invasive procedure associated with a high number of refusals. in a previous work on ida premenopausal women, gastroscopy was performed in all patients, later deemed unnecessary in almost 30% of the studied women because these were affected only by menorrhagia.

A research team led by Bruno Annibale from Italy prospectively evaluate the usefulness of a pre-endoscopic serological screening for H. pylori infection and with the use of two tests (human recombinant tissue transglutaminase IgA antibodies and anti-H. pylori IgG antibodies) in women aged < 50 affected by ida in order to increase the compliance for gastroscopy. their study will be published on june 14, 2009 in the

In this study, 115 women aged < 50 years with ida were tested by human recombinant tissue transglutaminase iga antibodies (ttg) and anti-H. pylori IgG antibodies. All cases underwent gastroscopy with biopsies of stomach and duodenum, irrespective of tests results. Of the 115 patients, 45.2% of women were test-positive. The serological results were confirmed by gastroscopy in 100% of those with positive H. pylori antibodies, in 50% of those with positive tTG and in 81.5% of test-negative patients. Sensitivity and specificity were 84.8% and 100% for H. pylori infection, and 80% and 92.8% for tTG, respectively. The gastroscopy compliance rate of test-positive women was significantly increased in comparison with those test-negative (65.4% vs 42.8%; Fisher test P = 0.0239).

This study showed that two simples and widely available tests, such as those for tissue transglutaminase IgA antibodies and anti-H. pylori IgG antibodies, were able to select women with IDA to submit for gastroscopy to identify IDA-related GI causes and to increase the compliance for the invasive procedure. Gastroscopy with biopsies confirmed in the vast majority of IDA women the presence of active H. pylori pangastritis, atrophic gastric body, or celiac disease as possible causes of IDA.

More information: Vannella L, Gianni D, Lahner E, Amato A, Grossi E, Delle, Fave G, Annibale B. Pre-endoscopic screening for and celiac disease in young anemic women. World J Gastroenterol 2009; 15(22): 2748-2753 http://www.wjgnet.com/1007-9327/15/2748.asp

Source: World Journal of Gastroenterology (news : web)

Related Stories

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.